Proton magnetic resonance spectroscopy in pituitary macroadenomas: Preliminary results - Laboratory investigation

Journal of Neurosurgery

Volumn 109, Issue 2, 2008, Pages 306-312

  Stadlbauer, Andreas ^a,b   Buchfelder, Michael ^a   Nimsky, Christopher ^a   Saeger, Wolfgang ^c   Salomonowitz, Erich ^b   Pinker, Katja ^d   Richter, Gregor ^a   Akutsu, Hiroyoshi ^a   Ganslandt, Oliver ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Landesklinikum ^*  (Germany)

^c Marienkrankenhaus Hamburg   (Germany)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Hemorrhage; Magnetic resonance spectroscopy; Pituitary macroadenoma; Preoperative diagnosis; Proliferation

Indexed keywords

CHOLINE; PROTON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TUMOR BLEEDING; ACTH SECRETING ADENOMA; ADENOMA; BRAIN HEMORRHAGE; CELL DIVISION; CLINICAL TRIAL; GROWTH HORMONE SECRETING ADENOMA; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PREOPERATIVE CARE; PROLACTINOMA;

ACTH-SECRETING PITUITARY ADENOMA; ADENOMA; ADULT; AGED; CELL DIVISION; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; INTRACRANIAL HEMORRHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROLACTINOMA; PROTONS;

EID: 51449118369     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/JNS/2008/109/8/0306     Document Type: Article

References (34)

1. Abe T, Sanno N, Osamura YR, Matsumoto K: Proliferative potential in pituitary adenomas: measurement by monoclonal antibody MIB-1. Acta Neurochir (Wien) 139:613-618, 1997 (Pubitemid 27298211)
2. Anzalone N, Scotti R, Riva R: Neuroradiologic differential diagnosis of cerebral intraparenchymal hemorrhage. Neurol Sci 25 (1 Suppl):S3-S5, 2004 (Pubitemid 38401389)
3. Arnold DL, Emrich JF, Shoubridge EA, Villemure JG, Feindel W: Characterization of astrocytomas, meningiomas, and pituitary adenomas by phosphorus magnetic resonance spectroscopy. J Neurosurg 74:447-453, 1991
4. Bonneville JF, Bonneville F, Cattin F: Magnetic resonance imaging of pituitary adenomas. Eur Radiol 15:543-548, 2005 (Pubitemid 40347894)
5. Bonneville F, Cattin F, Marsot-Dupuch K, Dormont D, Bonneville JF, Chiras J: T1 signal hyperintensity in the sellar region: spectrum of findings. Radiographics 26:93-113, 2006
6. Buchfelder M, Fahlbusch R, Adams EF, Kiesewetter F, Thierauf P: Proliferation parameters for pituitary adenomas. Acta Neurochir Suppl 65:18-21, 1996 (Pubitemid 126446152)
7. Caruso RD, Rosenbaum AE, Sherry RG, Wasenko JJ, Joy SE, Hochhauser L, et al: Pituitary gland. Variable signal intensities on MRI. A pictorial essay. Clin Imaging 22:327-332, 1998 (Pubitemid 28445809)
8. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133:1710-1715, 1984 (Pubitemid 14035254)
9. Herminghaus S, Pilatus U, Moller-Hartmann W, Raab P, Lanfermann H, Schlote W, et al: Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors. NMR Biomed 15:385-392, 2002
10. Honegger J, Prettin C, Feuerhake F, Petrick M, Schulte-Monting J, Reincke M: Expression of Ki-67 antigen in nonfunctioning pituitary adenomas: correlation with growth velocity and invasiveness. J Neurosurg 99:674-679, 2003 (Pubitemid 37159044)
11. Isobe T, Matsumura A, Anno I, Yoshizawa T, Nagatomo Y, Itai Y, et al: Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 20:343-349, 2002
12. Kinoshita Y, Kajiwara H, Yokota A, Koga Y: Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. Neurosurgery 35:606-614, 1994 (Pubitemid 24299893)
13. Kinoshita Y, Yokota A: Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10:2-12, 1997 (Pubitemid 27346611)
14. Kitz K, Knosp E, Koos WT, Korn A: Proliferation in pituitary adenomas: measurement by MAb KI 67. Acta Neurochir Suppl (Wien) 53:60-64, 1991
15. Knosp E, Kitz K, Perneczky A: Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25:927-930, 1989 (Pubitemid 20073386)
16. Kurihara N, Takahashi S, Higano S, Ikeda H, Mugikura S, Singh LN, et al: Hemorrhage in pituitary adenoma: correlation of MR imaging with operative findings. Eur Radiol 8:971-976, 1998 (Pubitemid 128662742)
17. Losa M, Franzin A, Mangili F, Terreni MR, Barzaghi R, Veglia F, et al: Proliferation index of nonfunctioning pituitary adenomas: correlations with clinical characteristics and longterm follow-up results. Neurosurgery 47:1313-1318, 2000
18. Majos C, Alonso J, Aguilera C, Serrallonga M, Acebes JJ, Arus C, et al: Adult primitive neuroectodermal tumor: proton MR spectroscopic findings with possible application for differential diagnosis. Radiology 225:556-566, 2002 (Pubitemid 35239262)
19. Matsumura A, Isobe T, Anno I, Takano S, Kawamura H: Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci 12:416-420, 2005 (Pubitemid 40745226)
20. Michaelis T, Merboldt KD, Bruhn H, Hanicke W, Frahm J: Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187:219-227, 1993 (Pubitemid 23097888)
21. Miller BL: A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline. NMR Biomed 4:47-52, 1991
22. Nakabayashi H, Sunada I, Hara M: Immunohistochemical analyses of cell cycle-related proteins, apoptosis, and proliferation in pituitary adenomas. J Histochem Cytochem 49:1193-1194, 2001 (Pubitemid 32800543)
23. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, et al: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84:449-458, 1996 (Pubitemid 26062870)
24. Ott D, Hennig J, Ernst T: Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 186:745-752, 1993 (Pubitemid 23073517)
25. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679, 1993
26. Shino A, Nakasu S, Matsuda M, Handa J, Morikawa S, Inubushi T: Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. J Neurosurg 91:928-934, 1999
27. Spiller M, Childress SM, Koenig SH, Duffy KR, Valsamis MP, Tenner MS, et al: Secretory and nonsecretory pituitary adenomas are distinguishable by 1/T1 magnetic relaxation rates at very low magnetic fields in vitro. Invest Radiol 32:320-329, 1997 (Pubitemid 27237568)
28. Stadlbauer A, Gruber S, Nimsky C, Fahlbusch R, Hammen T, Buslei R, et al: Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging. Radiology 238:958-969, 2006 (Pubitemid 43289928)
29. Tanaka Y, Hongo K, Tada T, Sakai K, Kakizawa Y, Kobayashi S: Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index. J Neurosurg 98:359-365, 2003 (Pubitemid 36151032)
30. Turner HE, Wass JA: Are markers of proliferation valuable in the histological assessment of pituitary tumours? Pituitary 1:147-151, 1999
31. Usenius JP, Kauppinen RA, Vainio PA, Hernesniemi JA, Vapalahti MP, Paljarvi LA, et al: Quantitative metabolite patterns of human brain tumors: detection by 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 18:705-713, 1994
32. Wismer GL, Buxton RB, Rosen BR, Fisel CR, Oot RF, Brady TJ, et al: Susceptibility induced MR line broadening: applications to brain iron mapping. J Comput Assist Tomogr 12:259-265, 1988
33. Wolfsberger S, Wunderer J, Zachenhofer I, Czech T, Bocher-Schwarz HG, Hainfellner J, et al: Expression of cell proliferation markers in pituitary adenomas-correlation and clinical relevance of MIB-1 and anti-topoisomerase- IIalpha. Acta Neurochir (Wien) 146:831-839, 2004 (Pubitemid 39024942)
34. Zou KH, Tuncali K, Silverman SG: Correlation and simple linear regression. Radiology 227:617-622, 2003 (Pubitemid 36583011)